Reata Pharmaceuticals, Inc. - (RETA): $78.35

0.08 (+0.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Reata Pharmaceuticals Inc (RETA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Reata Pharmaceuticals Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
9 $322 $155 $232.11 $81.62 184.38%

The Trend in the Analyst Price Target


Over the past 121 days, RETA's average price target has gone down $13.39.

Over the past 332 days, RETA's average upside potential has been 107.01%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 9 322 155 232.11 85.06 172.88%
2021-04-25 8 322 200 243.38 88.41 175.29%
2021-04-17 8 322 200 243.38 90.87 167.83%
2021-04-10 8 322 200 243.38 88.42 175.25%
2021-04-03 8 322 200 243.38 100.62 141.88%
2021-03-20 8 322 200 243.38 115.66 110.43%
2021-03-13 8 322 200 243.38 132.81 83.25%
2021-03-03 8 322 200 243.38 129.86 87.42%
2021-02-27 8 320 212 246.75 122.26 101.82%
2021-02-20 8 320 212 246.75 125.28 96.96%
2021-02-13 8 320 212 246.75 123.75 99.39%
2021-02-06 8 320 212 246.75 114.95 114.66%
2021-01-30 8 320 212 246.75 103.59 138.2%
2021-01-23 8 320 212 246.75 113.37 117.65%
2021-01-16 8 320 212 246.75 111.93 120.45%
2021-01-07 8 320 212 245.50 125.00 96.4%
2020-12-30 8 320 212 245.50 125.01 96.38%
2020-12-26 8 320 212 245.50 132.55 85.21%
2020-12-19 8 320 212 245.50 121.63 101.84%
2020-12-10 8 320 212 245.50 123.89 98.16%
2020-12-07 8 320 212 245.50 133.95 83.28%
2020-11-28 8 320 212 245.50 157.26 56.11%
2020-11-09 7 345 212 255.43 174.66 46.24%
2020-10-24 8 345 169 236.25 117.28 101.44%
2020-08-10 8 345 169 236.25 104.41 126.27%
2020-07-29 8 345 237 281.12 154.20 82.31%
2020-07-09 8 345 237 281.12 156.12 80.07%
2020-06-30 8 345 237 285.50 156.02 82.99%
2020-06-13 8 345 237 285.50 163.25 74.89%
2020-06-13 7 345 254 292.43 163.25 79.13%
2020-06-10 7 345 254 292.43 130.92 123.37%

RETA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.12 6 2 0 0 0 8

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RETA as an investment opportunity.

  • Reata Pharmaceuticals Inc's average analyst price target is higher than 95.03% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of RETA is higher than 97.88% of stocks in the mid market cap category.
  • Reata Pharmaceuticals Inc's variance in analysts' estimates is less than 12% of all US stocks.
  • RETA has a greater number of analysts covering the stock than 81.02% of Pharmaceutical Products stocks.

Stocks similar to Reata Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, ALBO and MIRM.

Is RETA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6287 seconds.